Outlook for the Chronic Myeloid Leukemia (CML) Treatment Market Through 2030: Size, Growth Rate, Trends
TBThe Business Research Company3 min read
Chronic Myeloid Leukemia (CML) Treatment
The Business Research Company
The Business Research Company’s Chronic Myeloid Leukemia Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, November 18, 2026 /EINPresswire.com/ -- The chronic myeloid leukemia (CML) treatment market has witnessed significant growth in recent years, driven by advancements in diagnosis and therapy as well as increasing awareness among patients and healthcare providers. As medical innovations continue to evolve, the market is set to experience further expansion, reflecting ongoing developments in targeted therapies and precision medicine.
Market Size and Growth Projections for the Chronic Myeloid Leukemia Treatment Market
The chronic myeloid leukemia treatment market has shown strong growth, expected to increase from $8.64 billion in 2025 to $9.23 billion in 2026, representing a compound annual growth rate (CAGR) of 6.8%. This historical growth has been fueled by improvements in diagnostic methods for blood cancers, the broader availability of first-generation tyrosine kinase inhibitors (TKIs), heightened awareness of CML, the expansion of oncology treatment centers, and better survival outcomes for patients.
Download a free sample of the chronic myeloid leukemia (cml) treatment market report:
https://thebusinessresearchcompany.com/sample_request?id=75298654&type=smp&name=Chronic%20Myeloid%20Leukemia%20%28CML%29%20Treatment%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR
Looking ahead, the market is forecasted to reach $12.17 billion by 2030, growing at a CAGR of 7.2%. The anticipated growth during this period is largely driven by the development of new targeted therapies, increasing use of combination treatment approaches, expansion of precision oncology initiatives, a stronger focus on patient adherence to therapy, and rising investments in oncology research. Key trends shaping this future growth include wider adoption of targeted therapy regimens, increased use of next-generation TKIs, growing emphasis on molecular diagnostics, personalized treatment protocols, and a greater focus on long-term disease management.
Understanding Chronic Myeloid Leukemia and Its Treatment
Chronic myeloid leukemia is a form of cancer that affects the blood and bone marrow, marked by an excessive proliferation of abnormal myeloid white blood cells. These cells typically play a crucial role in fighting infections and supporting the immune system. Treatment for CML aims to slow the disease progression and prevent it from advancing to more severe stages.
View the full chronic myeloid leukemia (cml) treatment market report:
https://thebusinessresearchcompany.com/report/chronic-myeloid-leukemia-CML-treatment-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR
Rising Prevalence of CML as a Key Market Driver
The growing number of individuals diagnosed with chronic myeloid leukemia is a significant factor propelling the treatment market forward. Also known as chronic myelogenous leukemia, this disease is characterized by an overproduction of immature white blood cells called myeloid cells. Effective CML treatments work to control this abnormal cell growth and delay progression. For example, in March 2023, the American Society of Clinical Oncology reported that approximately 35,730 new cases of multiple myeloma were expected in the United States in 2023, with 12,590 deaths projected. This rising incidence highlights the urgent need for effective treatments, thereby driving market expansion.
Geographical Market Insights Highlighting North America’s Position
In 2025, North America held the largest share of the chronic myeloid leukemia treatment market. The market analysis also includes regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a broad perspective on global market dynamics and regional growth opportunities.
New additions to our 2026 reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
![]()

